当前位置: X-MOL 学术Bioorg. Med. Chem. Lett. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Synthesis and biological evaluation of 1,6-bis-triazole-2,3,4-tri-O-benzyl-α-d-glucopyranosides as a novel α-glucosidase inhibitor in the treatment of Type 2 diabetes
Bioorganic & Medicinal Chemistry Letters ( IF 2.7 ) Pub Date : 2021-08-19 , DOI: 10.1016/j.bmcl.2021.128331
Suksamran Chaidam 1 , Natthiya Saehlim 1 , Anan Athipornchai 2 , Uthaiwan Sirion 2 , Rungnapha Saeeng 2
Affiliation  

A novel series of 1,6-bis-triazole-benzyl-α-glucoside derivatives (7a-7ee) were designed, synthesized and evaluated for inhibitory activity against α-glucosidase. Most of the synthesized compounds exhibited good activity with IC50 ranging from 3.73 µM to 53.34 µM and are more potent than the standard drug acarbose (IC50 = 146.25 ± 0.40 µM). SARs study showed the ester and menthol moiety play an important role in the inhibitory activity. The molecular docking model of the potent compounds 7f, 7z, 7cc and 7dd showed good binding energy and interacts well with amino acid residues around the active site of the enzyme, which confirmed the in vitro activity results.



中文翻译:

1,6-双-三唑-2,3,4-三-O-苄基-α-d-吡喃葡萄糖苷作为新型α-葡萄糖苷酶抑制剂治疗2型糖尿病的合成及生物学评价

设计、合成了一系列新的 1,6-双-三唑-苄基-α-葡萄糖苷衍生物 ( 7a-7ee ),并评估了其对α-葡萄糖苷酶的抑制活性。大多数合成化合物表现出良好的活性,IC 50范围为 3.73 µM 至 53.34 µM,比标准药物阿卡波糖 (IC 50  = 146.25 ± 0.40 µM)更有效。SARs研究表明酯和薄荷醇部分在抑制活性中起重要作用。强效化合物7f7z7cc7dd的分子对接模型显示出良好的结合能并与酶活性位点周围的氨基酸残基相互作用良好,这证实了体外活性结果。

更新日期:2021-08-25
down
wechat
bug